Biotech Showcase
Join us virtually
January 10–12, 2022 &January 17–19, 2022

Mylene Yao
CEO at Univfy


Mylene W. M. Yao is Co-founder and CEO of Univfy Inc., a predictive analytics company that uses machine learning to help more women access in vitro fertilization (IVF) treatments to build healthy families. Univfy is committed to reducing the financial barrier of IVF and increasing the per-patient IVF success rates.

Her vision is to make it easier for women and men to navigate complex decisions that can have life-altering impact -- with validated, personalized information and transparency. Under Mylene’s leadership, Univfy is supporting fertility specialists across the US and Canada by providing personalized IVF success probabilities to their patients based on health outcomes prediction models that are validated with each fertility center's data. She and her talented team have developed a proprietary, highly scalable, scientifically validated ML platform that has recently expanded to comprise prognostics-driven patient CRM, business analytics platform for providers and patient concierge services.

Mylene is a board-certified Ob/Gyn with over 20 years of experience in clinical and research roles in women’s health and reproductive medicine. Prior to founding Univfy, Mylene was an Assistant Professor at Stanford University, where she led NIH-funded fertility and embryo genetics research. She completed her clinical infertility fellowship at Brigham and Women’s Hospital, Harvard University (2001), Ob/Gyn residency at McGill University, Montreal (1998), and earned her medical degree at the University of Toronto (1993).

Agenda Sessions

  • Women’s Health: Progress and Innovation Continue to Drive Increased Investor Interest